KAREN EDGECOMB: Open Payments
NPI 1407101371 · BRIDGEWATER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 36 payments from 12 companies in 2025. Trend: 2023 $15 · 2024 $421 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $166 |
| Lilly USA, LLC | 8 | $143 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Corcept Therapeutics | 3 | $51 |
| Insulet Corporation | 2 | $39 |
| CeQur Corporation | 1 | $34 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Abbott Laboratories | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: FARXIGA, MOUNJARO, Wegovy, JARDIANCE, Rybelsus, Korlym, Omnipod, CeQur Simplicity.
Industry payments across NJ — which companies pay providers there.
